Poolbeg Pharma (POLB) Ord Shares
0.80p
(16.67%)
- Add to watchlist
- Create an alert
- This stock can be held in a
0.80p
(16.67%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
0.80p
(16.67%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
4.40p
4.50p
15.70p
£20.00 million
4.80p
3.70p
3.61p
n/a
0.05p (1.03%) Previous:
0.05p
7,979,697
n/a
30,000
Performance
| 1 week 1W | 18.37% | 1 year 1Y | 63.3% |
|---|---|---|---|
| 1 month 1M | 13.98% | 2 years 2Y | 55.8% |
| 3 months 3M | 47.37% | 3 years 3Y | 27.93% |
| 6 months 6M | 68.63% | 5 years 5Y | n/a |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Fundamental data
| Year ending: | 31/12/2023 | 31/12/2022 |
|---|---|---|
| Revenue (£m) | n/a | n/a |
| Profit before tax (£m) | (4.50) | (4.78) |
| Adjusted EPS (p): | (0.79) | (0.94) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Poolbeg shares slide as Hookipa terminates takeover talks
21 February 2025 10:38
-
Poolbeg Pharma says Gilead in favour of its combination with Hookipa
10 January 2025 16:06
-
Poolbeg Pharma granted new US patent
20 November 2024 13:56
-
Form 8.5 (EPT/RI) - Poolbeg Pharma Plc
21 February 2025 11:53
-
Termination of proposed combination with HOOKIPA
21 February 2025 07:00
-
HOOKIPA Pharma Inc. (“HOOKIPA”) Statement regarding potential combination for Poolbeg Pharma plc (“Poolbeg”)
20 February 2025 20:06
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.